These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17259486)

  • 1. Progression from newly acquired impaired fasting glusose to type 2 diabetes.
    Nichols GA; Hillier TA; Brown JB
    Diabetes Care; 2007 Feb; 30(2):228-33. PubMed ID: 17259486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
    Hong JL; McNeill AM; He J; Chen Y; Brodovicz KG
    Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1375-1386. PubMed ID: 27193175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius?
    Shaw JE; Zimmet PZ; de Courten M; Dowse GK; Chitson P; Gareeboo H; Hemraj F; Fareed D; Tuomilehto J; Alberti KG
    Diabetes Care; 1999 Mar; 22(3):399-402. PubMed ID: 10097917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of chronic kidney disease in young adults with impaired glucose tolerance/impaired fasting glucose: a retrospective cohort study using electronic primary care records.
    Jadhakhan F; Marshall T; Ryan R; Gill P
    BMC Nephrol; 2018 Feb; 19(1):42. PubMed ID: 29482513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes.
    Tsur A; Feldman BS; Feldhammer I; Hoshen MB; Leibowitz G; Balicer RD
    Diabetes Care; 2013 May; 36(5):1361-7. PubMed ID: 23393216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study.
    Han SJ; Kim HJ; Kim DJ; Lee KW; Cho NH
    Diabetes Res Clin Pract; 2017 Jan; 123():173-180. PubMed ID: 28043048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from optimal blood glucose and pre-diabetes to type 2 diabetes in a high risk population with or without hypertension in Isfahan, Iran.
    Janghorbani M; Amini M
    Diabetes Res Clin Pract; 2015 Jun; 108(3):414-22. PubMed ID: 25814432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.
    Kaneko K; Yatsuya H; Li Y; Uemura M; Chiang C; Hirakawa Y; Ota A; Tamakoshi K; Aoyama A
    J Diabetes Investig; 2020 Sep; 11(5):1163-1169. PubMed ID: 32022993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes in hemodialyzed patients when applying new diagnostic criteria.
    Elbert A; Schreier L; Galli C; Beresan H; Lopez G; Traversa M; Berg G
    J Ren Nutr; 2006 Oct; 16(4):300-3. PubMed ID: 17046613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired fasting glucose and impaired glucose tolerance in rural population of Bangladesh.
    Rahim MA; Azad Khan AK; Nahar Q; Ali SM; Hussain A
    Bangladesh Med Res Counc Bull; 2010 Aug; 36(2):47-51. PubMed ID: 21473200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.
    Nichols GA; Hillier TA; Brown JB
    Am J Med; 2008 Jun; 121(6):519-24. PubMed ID: 18501234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of glucose abnormalities and diagnostic value of fasting glucose and fasting insulin in urban Hispanics.
    Hoffmann IS; Alfieri AB; Cubeddu LX
    Am J Ther; 2013; 20(4):369-75. PubMed ID: 23528370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome the study from Jiangsu, China of 5 years follow-up.
    Liu SJ; Guo ZR; Hu XS; Wu M; Chen FM; Kang GD; Zhou H; Guo L
    Diabetes Res Clin Pract; 2008 Jul; 81(1):117-23. PubMed ID: 18485514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic characteristics and insulin resistance of impaired fasting glucose among the middle-aged and elderly Taiwanese.
    Chen LK; Lin MH; Chen ZJ; Hwang SJ; Tsai ST; Chiou ST
    Diabetes Res Clin Pract; 2006 Feb; 71(2):170-6. PubMed ID: 16026886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
    Fu SN; Luk W; Wong CK; Cheung KL
    J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study.
    Wang L; Cui L; Wang Y; Vaidya A; Chen S; Zhang C; Zhu Y; Li D; Hu FB; Wu S; Gao X
    Int J Epidemiol; 2015 Apr; 44(2):689-99. PubMed ID: 26002923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.